Amit V. Khera,Hong-Hee Won,Gina M. Peloso,Colm O'Dushlaine,Dajiang Liu,Nathan O. Stitziel,Pradeep Natarajan,Akihiro Nomura,Connor A. Emdin,Namrata Gupta,Ingrid B. Borecki,Rosanna Asselta,Stefano Duga,Piera Angelica Merlini,Adolfo Correa,Thorsten Kessler,James G. Wilson,Matthew J. Bown,Alistair S. Hall,Peter S. Braund,David J. Carey,Michael F. Murray,H. Lester Kirchner,Joseph B. Leader,Daniel R. Lavage,J. Neil Manus,Dustin N. Hartzel,Nilesh J. Samani,Heribert Schunkert,Jaume Marrugat,Roberto Elosua,Ruth McPherson,Martin Farrall,Hugh Watkins,Eric S. Lander,Daniel J. Rader,John Danesh,Diego Ardissino,Stacey Gabriel,Cristen Willer,Goncalo R. Abecasis,Danish Saleheen,Frederick E. Dewey,Sekar Kathiresan

Abstract:IMPORTANCE The activity of lipoprotein lipase (LPL) is the rate-determining step in clearing triglyceride-rich lipoproteins from the circulation. Mutations that damage the LPL gene (LPL) lead to lifelong deficiency in enzymatic activity and can provide insight into the relationship of LPL to human disease.OBJECTIVE To determine whether rare and/or common variants in LPL are associated with early-onset coronary artery disease (CAD).DESIGN, SETTING, AND PARTICIPANTS In a cross-sectional study, LPL was sequenced in 10 CAD case-control cohorts of the multinational Myocardial Infarction Genetics Consortium and a nested CAD case-control cohort of the Geisinger Health System DiscovEHR cohort between 2010 and 2015. Common variants were genotyped in up to 305 699 individuals of the Global Lipids Genetics Consortium and up to 120 600 individuals of the CARDIoGRAM Exome Consortium between 2012 and 2014. Study-specific estimates were pooled via meta-analysis.EXPOSURES Rare damaging mutations in LPL included loss-of-function variants and missense variants annotated as pathogenic in a human genetics database or predicted to be damaging by computer prediction algorithms trained to identify mutations that impair protein function. Common variants in the LPL gene region included those independently associated with circulating triglyceride levels.MAIN OUTCOMES AND MEASURES Circulating lipid levels and CAD.RESULTS Among 46 891 individuals with LPL gene sequencing data available, the mean (SD) age was 50 (12.6) years and 51% were female. A total of 188 participants (0.40%; 95% CI, 0.35%-0.46%) carried a damaging mutation in LPL, including 105 of 32 646 control participants (0.32%) and 83 of 14 245 participants with early-onset CAD (0.58%). Compared with 46 703 noncarriers, the 188 heterozygous carriers of an LPL damaging mutation displayed higher plasma triglyceride levels (19.6mg/dL; 95% CI, 4.6-34.6mg/dL) and higher odds of CAD (odds ratio = 1.84; 95% CI, 1.35-2.51; P < .001). An analysis of 6 common LPL variants resulted in an odds ratio for CAD of 1.51 (95% CI, 1.39-1.64; P = 1.1 x 10(-22)) per 1-SD increase in triglycerides.CONCLUSIONS AND RELEVANCE The presence of rare damaging mutations in LPL was significantly associated with higher triglyceride levels and presence of coronary artery disease. However, further research is needed to assess whether there are causal mechanisms by which heterozygous lipoprotein lipase deficiency could lead to coronary artery disease.

Whole-exome sequencing reveals damaging gene variants associated with hypoalphalipoproteinemia

Whole-exome Sequencing Identifies Rare and Low-Frequency Coding Variants Associated with LDL Cholesterol.

Whole Genome Sequence Analysis of Blood Lipid Levels in >66,000 Individuals

Exome Sequencing Identifies Rare LDLR and APOA5 Alleles Conferring Risk for Myocardial Infarction.

Exome-wide association analysis reveals novel coding sequence variants associated with lipid traits in Chinese

Identification of a Novel Mutation at the Point of Low Density Lipoprotein Receptor Gene from a Subject with Familial Hypercholesterolemia

Analysis of low-density lipoprotein receptor gene mutations in a family with familial hypercholesterolemia

Novel rare alleles of ABCA1 are exclusively associated with extreme high-density lipoprotein-cholesterol levels among the Han Chinese.

Exome Chip Meta-Analysis Identifies Novel Loci and East Asian–specific Coding Variants That Contribute to Lipid Levels and Coronary Artery Disease

Newly identified loci that influence lipid concentrations and risk of coronary artery disease

Conditional GWAS Revealing Genetic Impacts of Lifestyle Behaviors on Low-Density Lipoprotein (LDL)

Common Variants at 30 Loci Contribute to Polygenic Dyslipidemia

Association of Rare and Common Variation in the Lipoprotein Lipase Gene with Coronary Artery Disease

Combined analysis of genome scans of dutch and finnish families reveals a susceptibility locus for high-density lipoprotein cholesterol on chromosome 16q

Loss-of-function genomic variants with impact on liver-related blood traits highlight potential therapeutic targets for cardiovascular disease

A genome-wide linkage scan identifies multiple quantitative trait loci for HDL-cholesterol levels in families with premature CAD and MI

Rare Variant in Scavenger Receptor Bi Raises Hdl Cholesterol and Increases Risk of Coronary Heart Disease

A Novel Nonsense Mutation of ABCA8 in a Han-Chinese Family With ASCVD Leads to the Reduction of HDL-c Levels

Exome wide association study for blood lipids in 1,158,017 individuals from diverse populations

Genetic identification of familial hypercholesterolemia within a single U.S. health care system

Genetic Basis of HDL Variation in 129/svimj and C57BL/6J Mice: Importance of Testing Candidate Genes in Targeted Mutant Mice.